PDCD1 and Graves disease: In the course of anti-PD-1 treatment, the enhanced and disseminated uptake of fluorodeoxyglucose (FDG) in PET-CT (positron emission tomography) is particularly common for destructive thyroiditis (less common for Graves’ disease).